当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析

力生制药

(002393)

  

流通市值:48.64亿  总市值:50.07亿
流通股本:2.50亿   总股本:2.58亿

力生制药(002393)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.57亿元,每股收益0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益482923.57万元,未分配利润151609.55万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产577607.55万元,负债94683.98万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入369,840,643.71,336,154,449.871,023,773,647.92744,640,187.71
营业总成本305,793,020.681,211,524,253.09903,119,117.83630,232,979.54
营业利润67,216,791.48221,650,720.22201,408,039.28120,753,449.06
利润总额67,360,477.12215,948,800.36202,028,475.21120,640,637.48
净利润56,570,945.05185,960,824.83168,334,446.76101,280,724.76
其他综合收益--174,730,748.26--
综合收益总额56,570,945.0511,230,076.57168,334,446.76101,280,724.76
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,066,995,612.163,059,714,286.072,990,313,562.362,992,374,093.93
非流动资产合计2,709,079,907.492,725,797,526.213,026,362,122.563,058,424,883.71
资产总计5,776,075,519.655,785,511,812.286,016,675,684.926,050,798,977.64
流动负债合计707,592,100.78746,527,866.55746,481,208.37856,113,635.02
非流动负债合计239,247,706.21239,008,753.33267,411,320.91260,942,656.59
负债合计946,839,806.99985,536,619.881,013,892,529.281,117,056,291.61
归属于母公司股东权益合计4,797,881,012.734,769,916,090.814,970,581,596.64,901,696,778.19
股东权益合计4,829,235,712.664,799,975,192.45,002,783,155.644,933,742,686.03
负债和股东权益合计5,776,075,519.655,785,511,812.286,016,675,684.926,050,798,977.64
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计310,886,048.281,368,335,162.171,099,870,855.42755,509,083.11
经营活动现金流出小计311,863,659.861,280,071,805.761,008,074,998.87697,958,515.81
经营活动产生的现金流量净额-977,611.5888,263,356.4191,795,856.5557,550,567.3
投资活动现金流入小计1,249,819,229.11,999,668,452.611,285,504,522.13316,991,868.32
投资活动现金流出小计1,149,142,930.372,258,755,773.711,645,817,255.02672,396,258.05
投资活动产生的现金流量净额100,676,298.73-259,087,321.1-360,312,732.89-355,404,389.73
筹资活动现金流入小计61,104,30039,750,00039,750,00039,750,000
筹资活动现金流出小计103,995,214.11213,926,918.12173,963,819.71115,781,219.16
筹资活动产生的现金流量净额-42,890,914.11-174,176,918.12-134,213,819.71-76,031,219.16
汇率变动对现金及现金等价物的影响-745.47--
现金及现金等价物净增加额56,807,773.04-345,000,137.34-402,730,696.05-373,885,041.59
期末现金及现金等价物余额1,651,972,826.751,595,165,053.711,537,434,4951,566,280,149.46
最新报告期:2025-05-22
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券余汝意1.811.131.282025-05-22
TOP↑